Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 79Lung Neoplasms 44Carcinoma, Hepatocellular 43Small Cell Lung Carcinoma 28Breast Neoplasms 19Cholangiocarcinoma 17Urinary Bladder Neoplasms 16Biliary Tract Neoplasms 15Neoplasms 13Liver Neoplasms 13Neoplasm Metastasis 12Triple Negative Breast Neoplasms 11Pancreatic Neoplasms 11Ovarian Neoplasms 10Carcinoma 10Squamous Cell Carcinoma of Head and Neck 8Stomach Neoplasms 7Endometrial Neoplasms 7Colorectal Neoplasms 7Carcinoma, Transitional Cell 6Melanoma 5Gallbladder Neoplasms 5Esophageal Neoplasms 5Carcinoma, Renal Cell 5Adenocarcinoma Of Esophagus 5Adenocarcinoma 5Prostatic Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Neoplasms by Site 4Mesothelioma 4

Interventions

pembrolizumab 5Nivolumab 3durvalumab 2tremelimumab 1relatlimab 1fludarabine phosphate 1fludarabine 1avelumab 1atezolizumab 1Therapeutics 1Temozolomide 1Surgical Procedures, Operative 1Neoadjuvant Therapy 1Ipilimumab 1Injections 1Docetaxel 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Bevacizumab 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Microsatellite Instability × durvalumab × 1 year × Clear all
NCT03228667 2026-01-14

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

ImmunityBio, Inc.

Phase 2 Active not recruiting
40 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Microsatellite Instability, Small Cell Lung Carcinoma

NCT04817826 2025-06-10

INFINITY

Gruppo Oncologico del Nord-Ovest

Phase 2 Active not recruiting
31 enrolled
Gastrointestinal

Stomach Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡